Your browser doesn't support javascript.
loading
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
Tonneijck, Lennart; Smits, Mark M; Muskiet, Marcel H A; Hoekstra, Trynke; Kramer, Mark H H; Danser, A H Jan; Diamant, Michaela; Joles, Jaap A; van Raalte, Daniël H.
Afiliação
  • Tonneijck L; Department of Internal Medicine/Diabetes Center, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. l.tonneijck@vumc.nl.
  • Smits MM; Department of Internal Medicine/Diabetes Center, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
  • Muskiet MHA; Department of Internal Medicine/Diabetes Center, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
  • Hoekstra T; Department of Health Sciences and the EMGO Institute for Health and Care Research, VU University Amsterdam, Amsterdam, the Netherlands.
  • Kramer MHH; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Danser AHJ; Department of Internal Medicine/Diabetes Center, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
  • Diamant M; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Joles JA; Department of Internal Medicine/Diabetes Center, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands.
  • van Raalte DH; Department of Nephrology and Hypertension, University Medical Center, Utrecht, the Netherlands.
Diabetologia ; 59(7): 1412-1421, 2016 07.
Article em En | MEDLINE | ID: mdl-27038451
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Peçonhas / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda